RESUMEN
A biotécnica de refrigeração de sêmen equino para o trasporte de material genético está amplamente distribuida. Com a necessidade da manutenção da viabilidade espermática é indispensável a autilização e diluentes para este fim. O objetivo deste estudo foi avaliar se a adição de quercetina, que é um flavonóide antioxidante, em diluentes espermáticos altera a viabilidade dos espermatozoides equinos refrigerados. Foram avaliados cinco ejaculados de um garanhão, por meio da análise de motilidade e vigor espermático, em diferentes períodos de refrigeração em quatro meios de diluição: BotuSêmen®; BotuSêmen® adicionado de 20 µg/mL de quercetina (SIGMA®); Solução aquosa com 10% leite em pó desnatado (Molico®) ou Solução aquosa com 10% leite em pó desnatado (Molico®) adicionado de 20 µg/mL de quercetina (SIGMA®). Por meio dos resultados obtidos no presente estudo, foi possível verificar que não há diferença estatística entre a motilidade espermática de sêmen de garanhão diluído em BotuSêmen® em relação ao diluído solução aquosa com 10% leite em pó desnatado (Molico®) pelo período de refrigeração avaliado (36h).(AU)
The biotechnique of equine semen cooling for the transfer of genetic material is widely distributed. With the need to maintain sperm viability, it is indispensable to use and thinners for this purpose. The aim of this study was to evaluate whether the addition of quercetin, which is an anti-oxidant flavonoid, in spermatic diluents alters the viability of refrigerated equine spermatozoa. Five ejaculates of a stallion were evaluated by analysis of motility and spermatic vigor in different cooling periods in four dilution media: BotuSêmen® ; BotuSêmen® added 20 µg/mL of quercetin (SIGMA® ); Aqueous solution with 10% skimmilk powder (Molico® ) or Aqueous solution with 10% skimmilk powder (Molico® ) added 20 µg/mL quercetin (SIGMA® ). Through the data obtained, it was possible to verify that there is no statistical difference between the sperm motility of diluted stallion semen in BotuSêmen® in relation to the diluted aqueous solution with 10% skimmed milk powder (Molico® ) for the evaluated refrigeration period (36h).(AU)
Asunto(s)
Animales , Quercetina/administración & dosificación , Preservación de Semen/veterinaria , Refrigeración , Caballos , AntioxidantesRESUMEN
A biotécnica de refrigeração de sêmen equino para o trasporte de material genético está amplamente distribuida. Com a necessidade da manutenção da viabilidade espermática é indispensável a autilização e diluentes para este fim. O objetivo deste estudo foi avaliar se a adição de quercetina, que é um flavonóide antioxidante, em diluentes espermáticos altera a viabilidade dos espermatozoides equinos refrigerados. Foram avaliados cinco ejaculados de um garanhão, por meio da análise de motilidade e vigor espermático, em diferentes períodos de refrigeração em quatro meios de diluição: BotuSêmen®; BotuSêmen® adicionado de 20 µg/mL de quercetina (SIGMA®); Solução aquosa com 10% leite em pó desnatado (Molico®) ou Solução aquosa com 10% leite em pó desnatado (Molico®) adicionado de 20 µg/mL de quercetina (SIGMA®). Por meio dos resultados obtidos no presente estudo, foi possível verificar que não há diferença estatística entre a motilidade espermática de sêmen de garanhão diluído em BotuSêmen® em relação ao diluído solução aquosa com 10% leite em pó desnatado (Molico®) pelo período de refrigeração avaliado (36h).
The biotechnique of equine semen cooling for the transfer of genetic material is widely distributed. With the need to maintain sperm viability, it is indispensable to use and thinners for this purpose. The aim of this study was to evaluate whether the addition of quercetin, which is an anti-oxidant flavonoid, in spermatic diluents alters the viability of refrigerated equine spermatozoa. Five ejaculates of a stallion were evaluated by analysis of motility and spermatic vigor in different cooling periods in four dilution media: BotuSêmen® ; BotuSêmen® added 20 µg/mL of quercetin (SIGMA® ); Aqueous solution with 10% skimmilk powder (Molico® ) or Aqueous solution with 10% skimmilk powder (Molico® ) added 20 µg/mL quercetin (SIGMA® ). Through the data obtained, it was possible to verify that there is no statistical difference between the sperm motility of diluted stallion semen in BotuSêmen® in relation to the diluted aqueous solution with 10% skimmed milk powder (Molico® ) for the evaluated refrigeration period (36h).
Asunto(s)
Animales , Antioxidantes , Caballos , Preservación de Semen/veterinaria , Quercetina/administración & dosificación , RefrigeraciónRESUMEN
A biotécnica de refrigeração de sêmen equino para o trasporte de material genético está amplamente distribuida. Com a necessidade da manutenção da viabilidade espermática é indispensável a autilização e diluentes para este fim. O objetivo deste estudo foi avaliar se a adição de quercetina, que é um flavonóide antioxidante, em diluentes espermáticos altera a viabilidade dos espermatozoides equinos refrigerados. Foram avaliados cinco ejaculados de um garanhão, por meio da análise de motilidade e vigor espermático, em diferentes períodos de refrigeração em quatro meios de diluição: BotuSêmen®; BotuSêmen® adicionado de 20 µg/mL de quercetina (SIGMA®); Solução aquosa com 10% leite em pó desnatado (Molico®) ou Solução aquosa com 10% leite em pó desnatado (Molico®) adicionado de 20 µg/mL de quercetina (SIGMA®). Por meio dos resultados obtidos no presente estudo, foi possível verificar que não há diferença estatística entre a motilidade espermática de sêmen de garanhão diluído em BotuSêmen® em relação ao diluído solução aquosa com 10% leite em pó desnatado (Molico®) pelo período de refrigeração avaliado (36h).
RESUMEN
BACKGROUND: The relapsing nature of melasma emphasizes the need to maintain efficacy achieved after acute treatment. OBJECTIVE: To compare clinical efficacy and safety of two 6-month Triple Combination (TC; containing fluocinolone acetonide, hydroquinone and tretinoin) maintenance regimens in subjects with moderate to severe melasma, after daily treatment up to 8 weeks. METHODS: This randomized, investigator-blinded, controlled study had a maintenance phase of 6 months. Sixteen centres in Brazil and Mexico enrolled 242 subjects 18 years or older attaining no or mild melasma after 8 weeks of daily TC applications. Subjects were randomized to receive TC in a twice weekly or tapering regimen [3/week (1st month), 2/week (2nd month), 1/week (4th month)]. Efficacy and safety measurements included median time to relapse and relapse-free rate, Global Severity Score, Melasma Area and Severity Index score (MASI), subject's assessment, quality of life questionnaire (MelasQol), and adverse events. RESULTS: The majority (78.8%) had no or mild melasma (GSS ≤ 1) at week 8 and entered maintenance phase. After 6 months, 53% of patients remained relapse-free with improved quality of life, and time to relapse was similar between groups (about 190 days). Melasma severity at study entry, not maintenance baseline, influenced relapse rate. The twice weekly regimen tended to show better effectiveness in postponing relapse in severe melasma. Both regimens were safe. CONCLUSIONS: After resolution of melasma with TC, maintenance therapy over 6 months was successful in preventing relapse in over half of the patients who entered maintenance phase. Prescribing medicines should be adapted to patients based on melasma severity.
Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Melanosis/prevención & control , Fármacos Dermatológicos/administración & dosificación , Quimioterapia Combinada , Fluocinolona Acetonida/administración & dosificación , Fluocinolona Acetonida/uso terapéutico , Humanos , Hidroquinonas/administración & dosificación , Hidroquinonas/uso terapéutico , Melanosis/tratamiento farmacológico , Melanosis/patología , Calidad de Vida , Recurrencia , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Tretinoina/administración & dosificación , Tretinoina/uso terapéuticoRESUMEN
BACKGROUND: Pigmentation disorders, such as melasma, greatly influence the quality of life (QoL) of affected individuals who usually consider the disorder to be more severe than the objective clinical scores. Several instruments have been successfully developed to evaluate QoL. However, they must be adapted to the target population in terms of language and cultural diversity. The first, specific QoL questionnaire for melasma (MelasQoL) was developed for English speaking patients. OBJECTIVES: To validate the Brazilian Portuguese version of the MelasQoL evaluation questionnaire for patients with melasma (MelasQoL-BP) and to assess the impact of treatment with a triple combination cream (hydroquinone, fluocinolone acetonide and tretinoin) on the QoL of patients with moderate-to-severe melasma. METHODS AND RESULTS: Three hundred individuals from the five Brazilian geographic regions took part in this multicentre study. Their mean age was 42 years and skin phototype distribution was: type II 7.0% of patients, III 23.7%, IV 42.7% and V 22.7%. Melasma Area and Severity Index (MASI), MelasQoL-BP and the short version of the QoL assessment instrument from the World Health Organization (WHOQOL-BREF) were used to assess melasma severity and QoL at baseline. MelasQoL-BP was previously translated and culturally adapted from the English version, with participation of the authors and according to the standards of the World Health Organization (WHO). From the original sample, we randomized150 volunteers to treat melasma and repeated the evaluation after 8 weeks. The analysis of the MelasQoL-BP baseline answers demonstrated an important impact of the disease on skin appearance (65% of patients were bothered all the time or most of the time), frustration (55%), embarrassment (57%) and influence of the disease on interpersonal relationships (42%). Forty-three per cent of patients felt not attractive or even dirty due to their skin condition. MelasQoL-BP results showed significant internal consistency (Cronbach's alpha coefficient 0.919; P < 0.001) and good correlation with MASI scores. After treatment, the global assessment showed good or excellent results in 91.4% of the patients. The clinical outcome was not associated with the initial MASI score (P = 0.814; chi-square), skin colour (P = 0.449; probability ratio) or skin pigmentation (P = 0.814; chi-square). There was also a significant reduction on MelasQoL-BP scores (Wilcoxon test; P < 0.001) after treatment, with the mean +/- SD results shifting from 44.4 +/- 14.9 at baseline to 24.3 +/- 15.5 after treatment. The analysis of the MelasQoL-BP before and after treatment showed an important effect of the impact of treatment on a number of QoL measures. Of note, skin appearance (69.8 vs. 10.1% of patients were bothered all the time or most of the time, respectively), frustration (59.7% vs. 12.2%, respectively), embarrassment (56% vs. 9.3%, respectively) and influence of the disease on interpersonal relationships (35.3% vs. 5.8%, respectively) were greatly improved. CONCLUSIONS: This study demonstrates that MelasQoL-BP is a valid instrument and can be used to evaluate the quality of life and response to melasma treatment in Brazilian patients. The triple combination treatment produced significant results, regarding both clinical severity and quality of life.
Asunto(s)
Melanosis/psicología , Calidad de Vida , Encuestas y Cuestionarios , Adulto , Quimioterapia Combinada , Femenino , Fluocinolona Acetonida/uso terapéutico , Glucocorticoides/uso terapéutico , Humanos , Hidroquinonas/uso terapéutico , Queratolíticos/uso terapéutico , Lenguaje , Masculino , Melanosis/tratamiento farmacológico , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Reproducibilidad de los Resultados , Tretinoina/uso terapéuticoRESUMEN
The present study evaluated the acute effect of the intraperitoneal (ip) administration of a whey protein hydrolysate (WPH) on systolic arterial blood pressure (SBP) and renal sodium handling by conscious spontaneously hypertensive rats (SHR). The ip administration of WPH in a volume of 1 ml dose-dependently lowered the SBP in SHR 2 h after administration at doses of 0.5 g/kg (0.15 M NaCl: 188.5 ± 9.3 mmHg vs WPH: 176.6 ± 4.9 mmHg, N = 8, P = 0.001) and 1.0 g/kg (0.15 M NaCl: 188.5 ± 9.3 mmHg vs WPH: 163.8 ± 5.9 mmHg, N = 8, P = 0.0018). Creatinine clearance decreased significantly (P = 0.0084) in the WPH-treated group (326 ± 67 æL min-1 100 g body weight-1) compared to 0.15 M NaCl-treated (890 ± 26 æL min-1 100 g body weight-1) and captopril-treated (903 ± 72 æL min-1 100 g body weight-1) rats. The ip administration of 1.0 g WPH/kg also decreased fractional sodium excretion to 0.021 ± 0.019 percent compared to 0.126 ± 0.041 and 0.66 ± 0.015 percent in 0.15 M NaCl and captopril-treated rats, respectively (P = 0.033). Similarly, the fractional potassium excretion in WPH-treated rats (0.25 ± 0.05 percent) was significantly lower (P = 0.0063) than in control (0.91 ± 0.15 percent) and captopril-treated rats (1.24 ± 0.30 percent), respectively. The present study shows a decreased SBP in SHR after the administration of WPH associated with a rise in tubule sodium reabsorption despite an angiotensin I-converting enzyme (ACE)-inhibiting in vitro activity (IC50 = 0.68 mg/mL). The present findings suggest a pathway involving ACE inhibition but measurements of plasma ACE activity and angiotensin II levels are needed to support this suggestion.
Asunto(s)
Animales , Masculino , Ratas , Hidrolisados de Proteína/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Presión Arterial/efectos de los fármacos , Proteínas de la Leche/farmacología , Captopril/farmacología , Electroforesis Capilar , Hidrolisados de Proteína/administración & dosificación , Pruebas de Función Renal , Potasio/orina , Proteínas de la Leche/administración & dosificación , Ratas Endogámicas SHR , Sodio/orinaRESUMEN
The present study evaluated the acute effect of the intraperitoneal (ip) administration of a whey protein hydrolysate (WPH) on systolic arterial blood pressure (SBP) and renal sodium handling by conscious spontaneously hypertensive rats (SHR). The ip administration of WPH in a volume of 1 ml dose-dependently lowered the SBP in SHR 2 h after administration at doses of 0.5 g/kg (0.15 M NaCl: 188.5 +/- 9.3 mmHg vs WPH: 176.6 +/- 4.9 mmHg, N = 8, P = 0.001) and 1.0 g/kg (0.15 M NaCl: 188.5 +/- 9.3 mmHg vs WPH: 163.8 +/- 5.9 mmHg, N = 8, P = 0.0018). Creatinine clearance decreased significantly (P = 0.0084) in the WPH-treated group (326 +/- 67 microL min-1 100 g body weight-1) compared to 0.15 M NaCl-treated (890 +/- 26 microL min-1 100 g body weight-1) and captopril-treated (903 +/- 72 microL min-1 100 g body weight-1) rats. The ip administration of 1.0 g WPH/kg also decreased fractional sodium excretion to 0.021 +/- 0.019% compared to 0.126 +/- 0.041 and 0.66 +/- 0.015% in 0.15 M NaCl and captopril-treated rats, respectively (P = 0.033). Similarly, the fractional potassium excretion in WPH-treated rats (0.25 +/- 0.05%) was significantly lower (P = 0.0063) than in control (0.91 +/- 0.15%) and captopril-treated rats (1.24 +/- 0.30%), respectively. The present study shows a decreased SBP in SHR after the administration of WPH associated with a rise in tubule sodium reabsorption despite an angiotensin I-converting enzyme (ACE)-inhibiting in vitro activity (IC50 = 0.68 mg/mL). The present findings suggest a pathway involving ACE inhibition but measurements of plasma ACE activity and angiotensin II levels are needed to support this suggestion.
Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Presión Sanguínea/efectos de los fármacos , Proteínas de la Leche/farmacología , Hidrolisados de Proteína/farmacología , Animales , Captopril/farmacología , Electroforesis Capilar , Pruebas de Función Renal , Masculino , Proteínas de la Leche/administración & dosificación , Potasio/orina , Hidrolisados de Proteína/administración & dosificación , Ratas , Ratas Endogámicas SHR , Sodio/orina , Proteína de Suero de LecheRESUMEN
Certain diseases of the nail complex cause hyperkeratosis or alterations of the shape of the nail plate. These conditions may be painful, may decrease the penetration of topical medicaments and may be ugly. The nail plate abrasion, performed with dermabrader device or sandpaper, has application in patients suffering from onychomycosis, psoriasis, subnail infections and haematomas. The technique facilitates the collection of scales for mycological examination, decreases treatment time (of topical monotherapy) for onychomycosis and provides greater comfort for the patient by reducing nail plate thickness. It can also be useful for the partial removal of the nail plate in cases of haematomas and subnail infections. Nail abrasion is an effective and inexpensive method, easily applied in either nail pathologies with hyperkeratosis of the nail plate or in those requiring partial removal of the plate.
RESUMEN
Botulinum A exotoxin has become an excellent therapeutic option to treat focal hyperhidrosis, but when the problem affects the palmar region the technique has some drawbacks. Pain with injection is difficult to tolerate and the large dose needed to treat both hands are two concerns, as well as muscle weakness secondary to botulinum toxin diffusion and the possibility of antibody production. All these problems limit the number of patients treated. The author's suggestion is to treat only the dominant hand, after performing a wrist block. The use of a device adapted from a cartridge rubber may help to control the injection depth and the risk of muscular weakness.
Asunto(s)
Toxinas Botulínicas Tipo A/administración & dosificación , Mano , Hiperhidrosis/terapia , Bloqueo Nervioso/métodos , Toxinas Botulínicas Tipo A/efectos adversos , Mano/inervación , Humanos , Inyecciones/efectos adversos , Inyecciones/instrumentación , Inyecciones/métodos , Nervio Mediano , Dolor/etiología , Dolor/prevención & control , Nervio Radial , Nervio CubitalRESUMEN
Paracoccidioidomycosis was studied in 62 patients from Brazil in the 10 year period between 1978 and 1988. In 46 patients included in a first group, the disease was active and in 16 patients included in a second group, the disease was cured. The study was conducted according to both the clinical form of the disease and the response to paracoccidioidin in both groups. In the first group, 10 patients presented the acute form, 12 presented the chronic unifocal form and 24 had the chronic multifocal form of the disease. As to the response to paracoccidioidin, in the first group 16 patients were negative and 30 were positive; in the second group, 11 were positive and 5 were negative. An immunological study was performed in all patients using in vivo methods such as skin tests and sensitization to DNCB and in vitro techniques such as total lymphocyte counts, T and B cell counts, leukocyte migration inhibition test, chemotaxis of total leukocytes and mononuclear leukocyte phagocytosis.
Asunto(s)
Paracoccidioidomicosis/inmunología , Enfermedad Aguda , Adolescente , Adulto , Anciano , Antígenos Fúngicos , Inhibición de Migración Celular , Quimiotaxis de Leucocito , Niño , Enfermedad Crónica , Estudios de Cohortes , Femenino , Proteínas Fúngicas , Humanos , Inmunidad Celular , Pruebas Intradérmicas , Recuento de Leucocitos , Activación de Linfocitos , Subgrupos Linfocitarios , Masculino , Persona de Mediana Edad , Paracoccidioides/inmunología , Paracoccidioides/aislamiento & purificación , Paracoccidioidomicosis/microbiología , FagocitosisRESUMEN
Serum kinetics of bothropic venom were evaluated in eight snakebite patients, who due to a national shortage, received no specific antivenom therapy. The cases were clinically classified as mild, moderate, and severe. Patients were bled sequentially and serum levels of venom were assayed by ELISA. Venom level ranges differed among the groups, with peak levels of less than 13 ng/ml, 32 ng/ml, and 120 ng/ml for the mild, moderate, and severe groups, respectively. There was no clear pattern of kinetics in the groups. Regression analysis involving the variables severity and peak venom levels yielded a statistically significant correlation (rs = 0.80, P less than 0.05). These data indicate that different amounts of circulating venom correlate with clinical severity, even in highly complex venoms, and stress the importance of careful clinical classification in the proper management of bothropic incidents.
Asunto(s)
Venenos de Crotálidos/sangre , Mordeduras de Serpientes/sangre , Brasil , Ensayo de Inmunoadsorción Enzimática , Humanos , Índice de Severidad de la Enfermedad , Mordeduras de Serpientes/complicacionesRESUMEN
1. We describe a "sandwich" enzyme-linked immunosorbent assay (ELISA) sensitive to quantities of scorpion (Tityus serrulatus) venom (TsV) in the range of 1-3 ng/ml sample. 2. Cross-reactivity with the venom from the rattlesnake Crotalus durissus terrificus and with venoms from several snakes of the Bothrops genus was detected only at concentrations higher than 1 microgram/ml sample. 3. A conventional ELISA is also described for the detection of antibodies against TsV. 4. Analysis by Western Blot (WB) demonstrated a 25-kDa protein band common to TsV and to the venoms of Bothrops moojeni, B. jararacussu and B. jararaca. 5. Venom from C. d. terrificus exhibited WB cross-reactive bands of 16 and 25 kDa with TsV.
Asunto(s)
Ensayo de Inmunoadsorción Enzimática/métodos , Venenos de Escorpión/análisis , Animales , Western Blotting , Cromatografía de Afinidad , Reacciones Cruzadas , Venenos de Crotálidos/inmunología , Estudios de Factibilidad , Masculino , Conejos , Venenos de Escorpión/inmunologíaRESUMEN
We describe a "sandwich" enzyme-linkedimmunosorbent assay (ELISA) sensitive to quantities of scorpion (Tityus serrulatus) venom (TsV) in the range of 1-3 ng?ml sample. Cross-reactivity with the venom from the rattlesnake Crotalus durissus terrificus and with venoms from several snakes of the Bothrops genus was detected only at concentrations higher than 1 *g/ml sample. A conventional ELISA is also described for the detection of antibodies against TsV. Analysis by Western Blot (WB) demonstrated a 25-kDa protein band common to TsV and to the venoms of Bothrops moojeni, B. jararacussu and B. jararaca. Venom from C. d. terrificus exhibited WB cross-reactive bands of 16 and 25 kDa with TsV
Asunto(s)
Conejos , Animales , Masculino , Inmunización , Inmunoglobulina G/análisis , Venenos de Escorpión/inmunología , Western Blotting , Cromatografía de Afinidad , Reacciones Cruzadas , Venenos de Crotálidos/inmunología , Ensayo de Inmunoadsorción EnzimáticaRESUMEN
In this study, renal function of 52 workers of a primary lead smelter located in Northeast Brazil was compared to a reference group of 44 otherwise similar workers of a paper mill. Renal dysfunction, defined by a serum creatinine level greater than or equal to 1.5 mg/dl, was found in 17 (32.7%) workers at the lead smelter, the exposed group, but in only 1 (2.3%) individual from the reference group. Workers from the exposed group also showed significantly higher mean serum uric acid levels. Renal dysfunction of workers from the exposed group was statistically associated with duration of the employment at the smelter and with age, but not with the levels of lead and zinc protoporphyrin in blood and delta-aminolevulinic acid in urine. The two groups presented similar rates of arterial hypertension. However, arterial hypertension was much more strongly associated with renal dysfunction in the lead workers.
Asunto(s)
Enfermedades Renales/inducido químicamente , Pruebas de Función Renal , Intoxicación por Plomo/sangre , Enfermedades Profesionales/inducido químicamente , Adulto , Creatinina/sangre , Tasa de Filtración Glomerular/efectos de los fármacos , Humanos , Enfermedades Renales/sangre , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/sangre , Ácido Úrico/sangreRESUMEN
In north-east Brazil, where plague infection is endemic, bacteriological and serological methods were employed during a two-year period to determine accurately the occurrence of human infection and to define certain epidemiological features of both human and rodent infection. There were 67 confirmed cases of plague, predominantly among males and children. Most of these cases occurred in two inland rural plateaux of Ceara State. Clustering of cases in place and time was common, as was a history of contact with rats. Peak occurrence was in November 1978, during the warm, harvest time of year. Rodent surveillance resulted in isolation of Yersinia pestis from 33 animals, most of them from the field rodent, Zygodontomys pixuna, in the States of Pernambuco and Ceara. Our results indicate a decline in the number of human cases from previous years but show that several foci remain active and that serological testing, in addition to routine bacteriological testing, can assist workers in maintaining the surveillance of both human and rodent plague in Brazil.